Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New model could help spot High-Risk COPD patients with hidden muscle loss

NCT ID NCT07136246

First seen Jan 31, 2026 · Last updated Jun 21, 2026 · Updated 20 times

Summary

This completed study from Fudan University looked at 200 older adults with COPD who also have sarcopenic obesity — a condition where people have both low muscle mass and excess body fat. Researchers used a device called InBody S10 to measure body composition and phase angle, aiming to build a model that predicts disease severity, quality of life, and risk of flare-ups or death. The goal is to improve early screening and personalized care for this specific group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Huadong hospital, Fudan University

    Shanghai, Shanghai Municipality, 200040, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple tool for doctors to predict health outcomes in older adults with both COPD and muscle loss with obesity, enabling earlier interventions.

What could go wrong

This is an observational study that only builds a model, not a treatment. The model may not be accurate for all patients or lead to direct improvements in care.

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.